These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9667957)

  • 1. Nucleosides and nucleotides. 177. 9-(6,7-dideoxy-beta-D-allo-hept-5- ynofuranosyl)adenine: a selective and potent ligand for P3 purinoceptor-like protein.
    Matsuda A; Kosaki H; Saitoh Y; Yoshimura Y; Minakawa N; Nakata H
    J Med Chem; 1998 Jul; 41(15):2676-8. PubMed ID: 9667957
    [No Abstract]   [Full Text] [Related]  

  • 2. Nucleosides and nucleotides. 200. Reinvestigation of 5'-N-ethylcarboxamidoadenosine derivatives: structure-activity relationships for P(3) purinoceptor-like proteins.
    Umino T; Yoshioka K; Saitoh Y; Minakawa N; Nakata H; Matsuda A
    J Med Chem; 2001 Jan; 44(2):208-14. PubMed ID: 11170630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of selective ligands for P3 purinoceptor-like protein (P3LP).
    Umino T; Yoshioka K; Saitoh Y; Minakawa N; Nakata H; Matsuda A
    Nucleic Acids Symp Ser; 2000; (44):19-20. PubMed ID: 12903247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoaffinity labeling of a P3 purinoceptor-like protein purified from rat brain membranes.
    Saitoh Y; Nakata H
    Biochem Biophys Res Commun; 1996 Feb; 219(2):469-74. PubMed ID: 8605011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of a unique adenosine binding site in rat brain using a selective ligand.
    Yoshioka K; Matsuda A; Nakata H
    Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):278-84. PubMed ID: 11251640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 9-(6,7-dideoxy-beta-D-allo-hept-5-ynofuranosyl)adenine on noradrenaline release from vascular sympathetic nerves.
    Shinozuka K; Ishii-Nozawa R; Takeuchi K; Minakawa N; Matsuda A; Nakata H; Kunitomo M
    Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):312-4. PubMed ID: 11251646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adenosine and its neuronal receptors].
    Malec D
    Postepy Hig Med Dosw; 1991; 45(6):497-508. PubMed ID: 1687611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ring-Constrained (N)-methanocarba nucleosides as adenosine receptor agonists: independent 5'-uronamide and 2'-deoxy modifications.
    Lee K; Ravi G; Ji XD; Marquez VE; Jacobson KA
    Bioorg Med Chem Lett; 2001 May; 11(10):1333-7. PubMed ID: 11392549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 2-alkynyl substituted 4'-thioadenosine derivatives and their binding affinities at the adenosine receptors.
    Liang CW; Choi WJ; Jeong LS
    Arch Pharm Res; 2008 Aug; 31(8):973-7. PubMed ID: 18787783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purinergic receptors in gastrointestinal inflammation.
    Kolachala VL; Bajaj R; Chalasani M; Sitaraman SV
    Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G401-10. PubMed ID: 18063703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N6-bicycloalkyladenosines with unusually high potency and selectivity for the adenosine A1 receptor.
    Trivedi BK; Bridges AJ; Patt WC; Priebe SR; Bruns RF
    J Med Chem; 1989 Jan; 32(1):8-11. PubMed ID: 2909748
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of spin-labeled probes for adenosine receptors.
    Ilas J; Pecar S; Hockemeyer J; Euler H; Kirfel A; Müller CE
    J Med Chem; 2005 Mar; 48(6):2108-14. PubMed ID: 15771453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic receptor ligands stimulate pro-opiomelanocortin gene expression in AtT-20 pituitary corticotroph cells.
    Zhao LF; Iwasaki Y; Oki Y; Tsugita M; Taguchi T; Nishiyama M; Takao T; Kambayashi M; Hashimoto K
    J Neuroendocrinol; 2006 Apr; 18(4):273-8. PubMed ID: 16503922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine and brain function.
    Fredholm BB; Chen JF; Cunha RA; Svenningsson P; Vaugeois JM
    Int Rev Neurobiol; 2005; 63():191-270. PubMed ID: 15797469
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family.
    Borrmann T; Abdelrahman A; Volpini R; Lambertucci C; Alksnis E; Gorzalka S; Knospe M; Schiedel AC; Cristalli G; Müller CE
    J Med Chem; 2009 Oct; 52(19):5974-89. PubMed ID: 19731917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization.
    Dalziel HH; Westfall DP
    Pharmacol Rev; 1994 Dec; 46(4):449-66. PubMed ID: 7899473
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of apoptosis induced by purine nucleosides in astrocytes.
    Di Iorio P; Kleywegt S; Ciccarelli R; Traversa U; Andrew CM; Crocker CE; Werstiuk ES; Rathbone MP
    Glia; 2002 May; 38(3):179-90. PubMed ID: 11968056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel insights into how purines regulate pituitary cell function.
    Rees DA; Scanlon MF; Ham J
    Clin Sci (Lond); 2003 May; 104(5):467-81. PubMed ID: 12578557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine: roles of different receptor subtypes in mediating histamine release from human and rodent mast cells.
    Yip KH; Wong LL; Lau HY
    Inflamm Res; 2009 Apr; 58 Suppl 1():17-9. PubMed ID: 19271132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.